In-Source CID Ramping (InCIDR) and Co-Variant Ion Analysis of Hydrophilic Interaction Chromatography (HILIC) Metabolomics

23 January 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A large proportion of the complexity and redundancy of LC-MS metabolomics data comes from adduct formation. To reduce such redundancy, many tools have been developed to recognize and annotate adduct ions. These tools rely on pre-defined adduct lists which are learned empirically from reverse phase LC-MS studies. Meanwhile, hydrophilic interaction chromatography (HILIC) is gaining popularity in metabolomics studies due to better performance on polar compounds. HILIC methods typically use high concentration of buffer salts for improved chromatography performance. It is therefore necessary to analyze the adduct formation in HILIC metabolomics. To this end, we developed co-variant ion analysis (COVINA) to investigate the metabolite adduct formation. Using this tool, we completely annotated 201 adduct and fragment ions of 10 metabolites. Many of the metabolite adduct ions are found to contain cluster ions of mobile phase additives. We further utilized COVINA to find the major ionization forms of metabolites. Our results show that for some metabolites the adduct ion signals can be >200-fold higher than the deprotonated form, offering better sensitivity for targeted metabolomics analysis. Finally, we developed the in-source CID ramping (InCIDR) method to analyze the intensity changes of the adduct and fragment ions of the metabolites. Our analysis demonstrates a promising method to distinguish the protonated/deprotonated ions of the metabolites from the adduct and fragment ions.

Keywords

Metabolomics
HILIC
in-source fragmentation

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.